Fennec Pharmaceuticals (FENC) Short Interest Ratio & Short Volume $6.65 +0.05 (+0.76%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$6.66 +0.01 (+0.23%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Fennec Pharmaceuticals Short Interest DataFennec Pharmaceuticals (FENC) has a short interest of 1.95 million shares, representing 8.51% of the float (the number of shares available for trading by the public). This marks a -2.50% decrease in short interest from the previous month. The short interest ratio (days to cover) is 17.5, indicating that it would take 17.5 days of the average trading volume of 52,387 shares to cover all short positions.Current Short Interest1,950,000 sharesPrevious Short Interest2,000,000 sharesChange Vs. Previous Month-2.50%Dollar Volume Sold Short$12.68 millionShort Interest Ratio17.5 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares27,560,000 sharesFloat Size22,910,000 sharesShort Percent of Float8.51%Today's Trading Volume56,786 sharesAverage Trading Volume52,387 sharesToday's Volume Vs. Average108% Short Selling Fennec Pharmaceuticals? Sign up to receive the latest short interest report for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFENC Short Interest Over TimeFENC Days to Cover Over TimeFENC Percentage of Float Shorted Over Time Fennec Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20251,950,000 shares $12.68 million -2.5%8.5%17.5 $6.50 1/15/20252,000,000 shares $11.44 million +1.0%8.7%16.9 $5.72 12/31/20241,980,000 shares $12.51 million -6.2%8.7%16.7 $6.32 12/15/20242,110,000 shares $12.77 million +0.5%9.2%17.8 $6.05 11/30/20242,100,000 shares $12.73 million +12.3%9.2%17.3 $6.06 11/15/20241,870,000 shares $7.46 million +5.1%8.1%17.9 $3.99 10/31/20241,780,000 shares $7.76 million -3.3%7.8%19.5 $4.36 10/15/20241,840,000 shares $8.56 million -0.5%9.1%22.3 $4.65 9/30/20241,850,000 shares $9.25 million +0.5%8.1%21.6 $5.00 9/15/20241,840,000 shares $10.06 million No Change8.1%19 $5.47 Get the Latest News and Ratings for FENC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20241,840,000 shares $10.25 million -3.7%8.0%19.2 $5.57 8/15/20241,910,000 shares $10.66 million -1.6%8.4%18.6 $5.58 7/31/20241,940,000 shares $12.55 million -0.5%8.5%14.3 $6.47 7/15/20241,950,000 shares $12.75 million +8.3%8.6%13.5 $6.54 6/30/20241,800,000 shares $11.00 million +1.7%8.0%11.9 $6.11 6/15/20241,770,000 shares $11.97 million No Change7.8%11.8 $6.76 5/31/20241,770,000 shares $12.00 million +1.7%7.9%10.6 $6.78 5/15/20241,740,000 shares $12.15 million -3.9%7.5%10.4 $6.98 4/30/20241,810,000 shares $16.62 million -3.2%7.8%13.7 $9.18 4/15/20241,870,000 shares $19.32 million +3.3%8.1%14.5 $10.33 3/31/20241,810,000 shares $20.13 million +7.1%9.1%16.4 $11.12 3/15/20241,690,000 shares $16.80 million -1.2%8.5%14.4 $9.94 2/29/20241,710,000 shares $16.19 million -2.3%8.6%13.9 $9.47 2/15/20241,750,000 shares $16.00 million -2.2%8.9%14.8 $9.14 1/31/20241,790,000 shares $17.88 million -3.8%9.1%15.3 $9.99 1/15/20241,860,000 shares $19.14 million -7.5%9.5%15.3 $10.29 12/31/20232,010,000 shares $22.55 million -1.5%9.2%15.6 $11.22 12/15/20232,040,000 shares $20.30 million +6.8%9.4%15 $9.95 11/30/20231,910,000 shares $16.43 million -2.6%8.8%19.1 $8.60 11/15/20231,960,000 shares $15.70 million +2.1%9.0%20.9 $8.01 10/31/20231,920,000 shares $13.21 million -0.5%8.7%23 $6.88 10/15/20231,930,000 shares $13.32 million +19.1%8.8%25.4 $6.90 9/30/20231,620,000 shares $12.17 million +1.3%7.4%22.7 $7.51 9/15/20231,600,000 shares $12.69 million -3.0%7.3%27.3 $7.93 8/31/20231,650,000 shares $13.46 million -0.6%7.5%15.2 $8.16 8/15/20231,660,000 shares $13.76 million +0.6%7.6%14.5 $8.29 7/31/20231,650,000 shares $14.70 million -2.9%7.5%13.3 $8.91 7/15/20231,700,000 shares $14.93 million -1.2%7.8%13.8 $8.78 6/30/20231,720,000 shares $15.19 million -1.2%7.9%13.6 $8.83 6/15/20231,740,000 shares $16.84 million +1.2%8.0%12.6 $9.68Do this Before Elon’s Reveal on March 17th (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 5/31/20231,720,000 shares $13.04 million +17.0%7.9%19.1 $7.58 5/15/20231,470,000 shares $11.23 million No Change6.7%17 $7.64 10/31/2022547,400 shares $4.82 million +17.4%2.9%3.6 $8.80 10/15/2022466,300 shares $3.67 million -6.3%2.4%3.3 $7.87 9/30/2022497,800 shares $4.03 million +1.1%2.6%3.9 $8.10 9/15/2022492,200 shares $3.31 million +39.7%2.6%4.3 $6.72 8/31/2022352,300 shares $2.47 million +16.2%1.6%7.1 $7.00 8/15/2022303,100 shares $2.06 million +64.7%1.4%8 $6.79 7/31/2022184,000 shares $1.23 million +18.3%0.9%6.3 $6.68 7/15/2022155,500 shares $1.04 million -1.3%0.7%5.3 $6.72 6/30/2022157,600 shares $879,408.00 -25.5%1.0%5.5 $5.58 6/15/2022211,400 shares $1.19 million -18.0%1.3%7.2 $5.61 5/31/2022257,900 shares $1.47 million -2.7%1.2%8 $5.71 5/15/2022265,100 shares $1.46 million -0.1%1.2%7.5 $5.52 4/30/2022265,300 shares $1.53 million -1.7%1.2%7.2 $5.78 4/15/2022269,800 shares $1.67 million -0.4%1.3%6.8 $6.20 3/31/2022270,800 shares $1.52 million -3.3%N/A5.9 $5.60 3/15/2022279,900 shares $1.46 million -0.7%1.3%4.8 $5.20 2/28/2022281,800 shares $1.58 million -5.8%1.3%4.1 $5.59 2/15/2022299,200 shares $1.45 million +2.6%1.4%2.1 $4.86 1/31/2022291,500 shares $1.36 million -7.5%1.4%1.9 $4.65 1/15/2022315,100 shares $1.46 million +4.0%N/A0 $4.63 12/31/2021302,900 shares $1.33 million -15.8%1.4%2 $4.40 12/15/2021359,700 shares $1.54 million -13.8%1.7%2.5 $4.28 11/30/2021417,400 shares $1.83 million -7.0%1.9%3.2 $4.39 11/15/2021448,900 shares $4.33 million -5.8%2.1%8.2 $9.65 10/29/2021476,400 shares $4.41 million +8.0%2.2%10.3 $9.26 10/15/2021441,000 shares $4.05 million -4.2%2.0%10.7 $9.19 9/30/2021460,400 shares $4.34 million -16.0%2.1%10 $9.42 9/15/2021547,800 shares $4.73 million -9.4%2.5%5.3 $8.64 8/31/2021604,900 shares $4.79 million -8.0%2.8%5 $7.92 8/13/2021657,800 shares $4.69 million -8.6%3.0%4.8 $7.13 7/30/2021719,300 shares $4.68 million -1.6%3.3%4.9 $6.51 7/15/2021731,300 shares $4.83 million +3.9%3.4%4.5 $6.61 6/30/2021703,700 shares $5.13 million -50.4%3.3%4.2 $7.29 6/15/20211,420,000 shares $9.40 million +3.7%6.6%9.9 $6.62 5/28/20211,370,000 shares $10.10 million -6.2%6.3%10.8 $7.37 5/14/20211,460,000 shares $9.05 million +2.8%6.7%12.5 $6.20 4/30/20211,420,000 shares $9.23 million +14.5%6.6%12.5 $6.50 4/15/20211,240,000 shares $8.00 million +14.8%N/A0 $6.45 3/31/20211,080,000 shares $6.97 million +8.0%5.6%10.4 $6.45 3/15/20211,000,000 shares $7.70 million +3.3%5.2%12.5 $7.70 2/26/2021967,900 shares $7.39 million +6.2%5.0%11.4 $7.64 2/12/2021911,300 shares $7.63 million +1.0%4.7%10.1 $8.37 1/29/2021902,600 shares $6.64 million -8.2%4.7%8.9 $7.36 1/15/2021983,200 shares $7.27 million -1.2%5.1%9.2 $7.39 12/31/2020994,700 shares $7.10 million -5.3%5.2%9.2 $7.14 12/15/20201,050,000 shares $7.95 million -13.2%5.4%7.9 $7.58 11/30/20201,210,000 shares $9.37 million -4.7%6.3%7.5 $7.74 11/15/20201,270,000 shares $10.86 million -5.9%6.6%6.7 $8.55Do this Before Elon’s Reveal on March 17th (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 10/30/20201,350,000 shares $10.42 million +7.1%7.0%5.2 $7.72 10/15/20201,260,000 shares $9.25 million -10.0%6.7%3.2 $7.34 9/30/20201,400,000 shares $8.48 million +1.5%7.4%3.4 $6.06 9/15/20201,380,000 shares $8.42 million +17.0%7.3%2.9 $6.10 8/31/20201,180,000 shares $6.47 million +11.3%6.3%2.5 $5.48 8/14/20201,060,000 shares $6.01 million -4.5%5.6%2.4 $5.67 7/31/20201,110,000 shares $9.37 million -9.0%5.2%3 $8.44 7/15/20201,220,000 shares $10.35 million -10.3%5.7%4.8 $8.48 6/30/20201,360,000 shares $11.12 million +164.4%6.4%6 $8.18 6/15/2020514,400 shares $4.32 million -6.2%2.4%3.4 $8.39 5/29/2020548,400 shares $4.06 million +2.6%2.7%4.5 $7.40 5/15/2020534,300 shares $3.92 million -20.7%2.7%4.9 $7.34 4/30/2020673,700 shares $4.87 million -2.5%3.4%6.4 $7.23 4/15/2020691,100 shares $4.38 million -19.0%4.2%10.1 $6.34 3/31/2020852,900 shares $6.46 million +27.8%5.2%12.7 $7.58 3/13/2020667,400 shares $4.31 million -0.4%4.1%9.5 $6.46 2/28/2020670,200 shares $3.53 million +19.9%4.1%12.1 $5.26 FENC Short Interest - Frequently Asked Questions What is Fennec Pharmaceuticals' current short interest? Short interest is the volume of Fennec Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 1,950,000 shares of FENC short. 8.51% of Fennec Pharmaceuticals' shares are currently sold short. Learn More on Fennec Pharmaceuticals' current short interest. What is a good short interest ratio for Fennec Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FENC shares currently have a short interest ratio of 18.0. Learn More on Fennec Pharmaceuticals's short interest ratio. Which institutional investors are shorting Fennec Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fennec Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Fennec Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.51% of Fennec Pharmaceuticals' floating shares are currently sold short. Is Fennec Pharmaceuticals' short interest increasing or decreasing? Fennec Pharmaceuticals saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 1,950,000 shares, a decrease of 2.5% from the previous total of 2,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Fennec Pharmaceuticals' float size? Fennec Pharmaceuticals currently has issued a total of 27,560,000 shares. Some of Fennec Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fennec Pharmaceuticals currently has a public float of 22,910,000 shares. How does Fennec Pharmaceuticals' short interest compare to its competitors? 8.51% of Fennec Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Fennec Pharmaceuticals: Anavex Life Sciences Corp. (27.55%), Opthea Limited (0.27%), Sana Biotechnology, Inc. (36.75%), LENZ Therapeutics, Inc. (11.14%), Relay Therapeutics, Inc. (9.36%), Immatics (8.39%), Cullinan Therapeutics, Inc. (23.70%), Autolus Therapeutics plc (3.42%), Valneva SE (0.05%), Tectonic Therapeutic (13.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Fennec Pharmaceuticals stock? Short selling FENC is an investing strategy that aims to generate trading profit from Fennec Pharmaceuticals as its price is falling. FENC shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fennec Pharmaceuticals? A short squeeze for Fennec Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FENC, which in turn drives the price of the stock up even further. How often is Fennec Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FENC, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Anavex Life Sciences Short Interest Opthea Short Interest Sana Biotechnology Short Interest LENZ Therapeutics Short Interest Relay Therapeutics Short Interest Immatics Short Interest Cullinan Therapeutics Short Interest Autolus Therapeutics Short Interest Valneva Short Interest Tectonic Therapeutic Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FENC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
